Response to Neoadjuvant Endocrine Therapy for Breast Cancer May Vary by Race
Race is a significant predictor of downstaging in HR+ breast cancer after adjustment for duration of NET, clinical stage
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.